Literature DB >> 32396751

Pharmacological and non-pharmacological pain relief for office hysteroscopy: an up-to-date review.

G Riemma1, A Schiattarella1, N Colacurci1, S G Vitale2, S Cianci1, A Cianci2, P De Franciscis1.   

Abstract

In-office hysteroscopy is considered the standard technique for visualization of the uterine cavity and the diagnosis of intrauterine pathologies. Moreover, nowadays, it is possible to treat a vast number of intracavitary diseases in the office, without the need for the inpatient setting. However, in some cases, pain might occur, and this is the most common reason for not completing the procedure. Over the last 20 years, many efforts have been carried out to miniaturize the instrumentation and to improve the techniques in order to avoid discomfort. Nonetheless, hysteroscopy still provokes distress for many patients. For this reason, pharmacological and non-pharmacological treatments for intraoperative and postoperative pain relief have been widely used for in-office hysteroscopy, with different results in various groups of women. The purpose of this review was to analyze the current literature on pharmacological aids (non-steroidal anti inflammatory drugs, cyclooxygenase-2 inhibitors, antispasmodics, local anesthetics, prostaglandins, opioids) and non-pharmacological interventions (transcutaneous electrical nerve stimulation, uterine stretching, uterine pressure, warming of distension medium, hypnosis, music, vocal-local) and to evaluate their impact on the relief from pain experienced during in-office hysteroscopy.

Entities:  

Keywords:  In-office hysteroscopy; non-pharmacological treatment; pain management; pharmacological treatment

Mesh:

Substances:

Year:  2020        PMID: 32396751     DOI: 10.1080/13697137.2020.1754388

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  4 in total

1.  Ascertaining the Effects of Tissue Sealers on Minor Laparoscopic Procedures between Obstetrics and Gynecology Residents: A Prospective Cohort Study.

Authors:  Pasquale De Franciscis; Marco La Verde; Luigi Cobellis; Antonio Mollo; Marco Torella; Fulvio De Simone; Gaetano Maria Munno; Emanuele Amabile; Carla Loreto; Angela Celardo; Nicola Fortunato; Gaetano Riemma
Journal:  Medicina (Kaunas)       Date:  2022-04-23       Impact factor: 2.948

2.  Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial.

Authors:  Xiaoqiang Zhang; Shuang Li; Jing Liu
Journal:  BMC Anesthesiol       Date:  2021-05-20       Impact factor: 2.217

Review 3.  Pain Management during Office Hysteroscopy: An Evidence-Based Approach.

Authors:  Giovanni Buzzaccarini; Luis Alonso Pacheco; Amerigo Vitagliano; Sergio Haimovich; Vito Chiantera; Péter Török; Salvatore Giovanni Vitale; Antonio Simone Laganà; Jose Carugno
Journal:  Medicina (Kaunas)       Date:  2022-08-20       Impact factor: 2.948

Review 4.  Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives.

Authors:  Salvatore Giovanni Vitale; Gaetano Riemma; Jose Carugno; Benito Chiofalo; George Angelos Vilos; Stefano Cianci; Mehmet Sukru Budak; Bernardo Portugal Lasmar; Antonio Raffone; Ilker Kahramanoglu
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.